Mangoceuticals, Inc.
MGRX
$1.73
$0.074.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -126.51% | -104.40% | 24.13% | -11.10% | -4.68% |
| Total Depreciation and Amortization | 2,472.92% | 6,593.55% | 11,357.14% | -95.24% | 424.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 267.69% | 337.81% | -36.77% | 217.83% | 98.06% |
| Change in Net Operating Assets | 130.46% | -82.51% | -12.60% | 81.82% | -688.19% |
| Cash from Operations | 20.34% | -129.52% | 33.46% | 31.85% | 11.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 500.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 345.74% | 530.56% | -36.67% | -- | -62.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -35.58% | 754.21% | -6.46% | -- | 132.01% |
| Foreign Exchange rate Adjustments | 118.18% | 7,700.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.84% | 102.46% | 96.93% | 75.66% | 151.42% |